Mar 26, 2025 · Rexulti (brexpiprazole) is a prescription antipsychotic medication used in the treatment of major depressive disorder, schizophrenia in adults and children aged 13 years …

Adjunctive treatment of major depressive disorder (MDD) in adults. The recommended starting dosage for REXULTI as adjunctive treatment of MDD in adults is 0.5 mg or 1 mg once daily, …

Feb 16, 2017 · In clinical trials, REXULTI was found to significantly improve both positive and negative symptoms. • use as an adjunct to antidepressants for the treatment of major …

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at increased risk of death. REXULTI is not approved for the treatment of patients with dementia-related...

Learn about REXULTI® (brexpiprazole), its uses and how it may help. See Important Safety Info & Full Prescribing Info, including Boxed WARNING.

Today, the U.S. Food and Drug Administration is announcing the supplemental approval of Rexulti (brexpiprazole) oral tablets for the treatment of agitation associated with dementia due to...

REXULTI ® (REX-ul-TE) (brexpiprazole) tablets, for oral use What is the most important information I should know about REXULTI? REXULTI may cause serious side effects, …

Jan 14, 2025 · REXULTI is indicated for: Adjunctive treatment of major depressive disorder (MDD) in adults - Treatment of schizophrenia in adults and pediatric patients ages 13 years and older …

REXULTI is an atypical antipsychotic indicated for: • Use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) (1, 14.1) • Treatment of...

REXULTI is not approved for the treatment of patients with dementia-related psychosis without agitation associated with dementia due to Alzheimer’s disease. (5.1) Antidepressants …